Inventor · disambiguated record
Narayan Ragunathan
Also filed as: RAGUNATHAN NARAYAN
7 granted patents·4 pending applications·72 citations·filing 1998–2013
85Inventor score
Files withPAR PHARMACEUTICAL INC5PHARMACEUTICAL RESOURCES INC3FEMIA ROBERT1RUBINO ORAPIN P1RUEMER ROBERT1
Top patents by PatentIndex Score
11 records- 0184US6593320B2Flocculated suspension of megestrol acetatePHARMACEUTICAL RESOURCES INC·Filed 2002·Granted Jul 15, 2003·16 cites·10 claims
- 0284US6593318B2Flocculated suspension of megestrol acetatePHARMACEUTICAL RESOURCES INC·Filed 2001·Granted Jul 15, 2003·15 cites·68 claims
- 0372US7246020B2System and method for sorting dataPAR PHARMACEUTICAL INC·Filed 2005·Granted Jul 17, 2007·4 cites·24 claims
- 0467US6028065AFlocculated suspension of megestrol acetatePHARMACEUTICAL RESOURCES INC·Filed 1998·Granted Feb 22, 2000·32 cites·19 claims
- 0566US7996170B2System and method for sorting dataPAR PHARMACEUTICAL INC·Filed 2009·Granted Aug 9, 2011·2 cites·19 claims
- 0666US7552020B2System and method for sorting dataPAR PHARMACEUTICAL INC·Filed 2007·Granted Jun 23, 2009·2 cites·25 claims
- 0760US8620596B2System and method for sorting dataRUEMER ROBERT·Filed 2011·Granted Dec 31, 2013·1 cites·15 claims
- 0856US2014101175A1System and method for sorting dataPAR PHARMACEUTICAL INC·Filed 2013·Application pending·0 cites
- 0953US2006013880A1Formulation stabilizer for proton pump inhibitorsFEMIA ROBERT·Filed 2004·Application pending·0 cites
- 1049US2004142903A1Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositionsPAR PHARMACEUTICAL INC·Filed 2003·Application pending·0 cites
- 1147US2007224269A1Controlled Release Pharmaceutical FormulationRUBINO ORAPIN P·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Narayan Ragunathan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →